Towards Clinical Application of Methylated DNA Sequences as Cancer Biomarkers: A Joint NCI's EDRN and NIST Workshop on Standards, Methods, Assays, Reagents and Tools.
The workshop report, entitled Towards Clinical Application of Methylated DNA Sequences as Cancer Biomarkers: A Joint National Cancer Institute's Early Detection Research Network and National Institute of Standards and Technology Workshop, presents a summary of the main issues, current challenges, outcomes, and recommendations toward application of methylated DNA sequences as cancer biomarkers.
Kagan
Jacob
J
Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, NIH, Bethesda, Maryland, USA. kaganj@mail.nih.gov
Srivastava
Sudhir
S
Barker
Peter E
PE
Belinsky
Steven A
SA
Cairns
Paul
P
D014408:Biomarkers, Tumor / Q000235:genetics*; D019175:DNA Methylation; D004273:DNA, Neoplasm / Q000097:blood / Q000235:genetics; D006801:Humans; D009369:Neoplasms / Q000097:blood / Q000175:diagnosis / Q000235:genetics*; D011401:Promoter Regions, Genetic; D013048:Specimen Handling / Q000379:methods
D014408:Biomarkers, Tumor; D004273:DNA, Neoplasm